test
Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Philadelphia, PA.
Notes: I don't think the company will continue generating enough capital to sustain its operations, requiring them (1) to either take out more loans or (2) file for chapter 7/11 in the not too distant future.
About the security: "Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers...
TEST
Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Philadelphia, PA.
Chart painting from the early 21st century, artist Maxi Scalibusa. No investment advice or a recommendation to buy or sell any securities. This is entertainment. Start 5.20 USD
What Is a Short Squeeze?
A short squeeze occurs when a stock or other
asset jumps sharply higher, forcing traders who
had bet that its price would fall, to buy it in
order to forestall even greater losses. Their
scramble to buy only adds to the upward
pressure on the stock's price
KEY TAKEAWAYS
*A short squeeze accelerates a stock's price rise
as short-sellers...
After Review Lannett Company, Inc
On the technical analysis:
We have a double bottom pattern.
the base is at 4.80
The resistance level is at 6.50
Quarterly Results
Earnings per share fell 16.22% year over year to $0.31, which beat the estimate of $0.29.
finance.yahoo.com
Lannett stock has struggled lately due to opioid litigation and a weakening of its earnings forecast back in November. However, the company announced several product launches in December and early January, and today Lannett got FDA approval for, of all things, a cocaine-based anesthetic nasal spray. The stock has shown little positive reaction to any of this news,...
Don't have to be a genius to see that this will have some level of pullback. Although, specifically, I'll target 7 and add to my short if it goes over 12.
On August 27, Lannett Company reported its fourth-quarter earnings results. The company reported revenues of $133.84 million, a year-over-year decline of 21.69%. However, this was $13.56 million higher than the consensus estimate. The company also reported non-GAAP EPS (earnings per share) of $0.37. This is $0.16 higher than the consensus.
Lannett Company has...
With an intraday move of currently 42.81%, and intraday high of $8.95 and a short float percentage of 74.27% LCI looks like an interesting short-squeeze opportunity. The RSI indicated several overbought conditions with a cross at the 69.95 level, that followed a sharp sell-off. If you are interested in finding optimal RSI levels for individual stocks, please check...
This isn't just any double bottom. This is a double bottom in a penny stock with awesome analyst ratings and some of the biggest short squeeze potential in the market right now. When this runs, it could run fast.
Potential Long setup on LCI; awaiting price confirmation at a higher level - high risk trade profile contingent on upcoming earnings. Hope to see price break higher on positive earnings report.
Trade responsibly; TPs and SLs
Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Trevose, PA.
NYSE
